20797904

Katz-Jaffe MG

2010

Blastocysts from patients with polycystic ovaries exhibit altered transcriptome and secretome.

20800551

Guo M

2010

Cardiovascular and metabolic characteristics of infertile Chinese women with PCOS diagnosed according to the Rotterdam consensus criteria.

20800834

Dursun E

2011

Periodontal disease in polycystic ovary syndrome.

20802107

Burt Solorzano CM

2010

Obesity and the pubertal transition in girls and boys.

20806187

Olszewska M

2010

Methods of hair loss evaluation in patients with endocrine disorders.

20806188

Medra? M

2010

Transsexualism--diagnostic and therapeutic aspects.

20807165

Vrb?kov? J

2011

Metabolic syndrome in adolescents with polycystic ovary syndrome.

20807166

Rocha MP

2011

Dyslipidemia in women with polycystic ovary syndrome: incidence, pattern and predictors.

20809108

Li L

2010

Elevated serum anti-mullerian hormone in adolescent and young adult Chinese patients with polycystic ovary syndrome.

20814540

Giulini S

2010

Adnexal Torsion during Pregnancy after Oocyte In Vitro Maturation and Intracytoplasmic Sperm Injection Cycle.

20816585

Petr?kov? J

2010

Polycystic ovary syndrome and autoimmunity.

20816944

Rosenfield RL

2010

Evidence that obesity and androgens have independent and opposing effects on gonadotropin production from puberty to maturity.

20817794

Sathyapalan T

2010

Atorvastatin increases 25-hydroxy vitamin D concentrations in patients with polycystic ovary syndrome.

20818087

Li H

2010

[Activin and activin receptors in related gynecologic and obstetric diseases].

20819662

Ma YM

2010

Characteristics of abnormal menstrual cycle and polycystic ovary syndrome in community and hospital populations.

20821044

Vieira RC

2011

Spindle and chromosome configurations of in vitro-matured oocytes from polycystic ovary syndrome and ovulatory infertile women: a pilot study.

20821267

Carroll TB

2010

The diagnosis of Cushing's syndrome.

20824862

Zhang J

2010

Chinese herbal medicine for subfertile women with polycystic ovarian syndrome.

20826578

Legro RS

2010

Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism.

20826585

Sokalska A

2010

Statins inhibit growth of human theca-interstitial cells in PCOS and non-PCOS tissues independently of cholesterol availability.

20826587

Margarit L

2010

MUC1 as a discriminator between endometrium from fertile and infertile patients with PCOS and endometriosis.

20828243

Ling J

2011

Heat shock protein 10 regulated apoptosis of mouse ovarian granulosa cells.

20832741

Simmons D

2010

Metformin treatment for Type 2 diabetes in pregnancy?

20833639

Harrison CL

2011

Exercise therapy in polycystic ovary syndrome: a systematic review.

20836726

Panidis D

2011

The impact of oral contraceptives and metformin on anti-M?llerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia.

20836727

Moradi S

2011

Relation between C-reactive protein and body mass index in patients with polycystic ovarian syndrome.

20840267

Xita N

2010

Fetal origins of the metabolic syndrome.

20840269

Escobar-Morreale HF

2010

Diagnosis and management of hirsutism.

20840270

Bruni V

2010

Polycystic ovary syndrome in adolescence.

20840271

Christopoulos P

2010

Peroxisome proliferator-activated receptor-? and -? polymorphisms in women with polycystic ovary syndrome.

20840272

Diamanti-Kandarakis E

2010

Metformin in polycystic ovary syndrome.

20840879

Zhao L

2011

Berberine reduces insulin resistance induced by dexamethasone in theca cells in vitro.

20842820

Maciejewska-Jeske M

2010

[Serum C-peptide concentration in overweight and obese women with polycystic ovary syndrome].

20843777

Rosas C

2010

Levels of Rabs and WAVE family proteins associated with translocation of GLUT4 to the cell surface in endometria from hyperinsulinemic PCOS women.

20843954

Burgers JA

2010

Oligoovulatory and anovulatory cycles in women with polycystic ovary syndrome (PCOS): what's the difference?

20846066

Tuuri A

2010

Hormonal and metabolic characteristics of premenopausal women with a history of preeclamptic pregnancy.

20846294

Glintborg D

2010

Ethnic differences in Rotterdam criteria and metabolic risk factors in a multiethnic group of women with PCOS studied in Denmark.

20848729

Vause TD

2010

Ovulation induction in polycystic ovary syndrome: No. 242, May 2010.

20849198

Brewer C

2010

Effect of metformin taken in the 'fresh' in vitro fertilization/intracytoplasmic sperm injection cycle upon subsequent frozen embryo replacement in women with polycystic ovary syndrome.

20852028

Tan BK

2010

Metformin treatment may increase omentin-1 levels in women with polycystic ovary syndrome.

20855553

Jordan CD

2010

Fibrillins in adult human ovary and polycystic ovary syndrome: is fibrillin-3 affected in PCOS?

20858697

Palomba S

2010

Six weeks of structured exercise training and hypocaloric diet increases the probability of ovulation after clomiphene citrate in overweight and obese patients with polycystic ovary syndrome: a randomized controlled trial.

20861609

Ojaniemi M

2010

Management of polycystic ovary syndrome in childhood and adolescence.

20862969

Huang D

2010

[Effects of bushen tongmai recipe on expression of phosphatidylinositol-3-kinase in PCOS rats accompanying with insulin resistance].

20865044

Dasgupta S

2010

Androgen receptor CAG repeat polymorphism and epigenetic influence among the south Indian women with Polycystic Ovary Syndrome.

20869052

Atabekoglu CS

2011

Increased monocyte chemoattractant protein-1 levels indicating early vascular damage in lean young PCOS patients.

20869703

Almog B

2011

Age-related normogram for antral follicle count: McGill reference guide.

20869715

Tan BK

2011

The anti-atherogenic aspect of metformin treatment in insulin resistant women with the polycystic ovary syndrome: role of the newly established pro-inflammatory adipokine Acute-phase Serum Amyloid A; evidence of an adipose tissue-monocyte axis.

20873125

Banaszewska B

2010

[Statins in the treatment of polycystic ovary syndrome].

20881256

Garside SA

2010

A thrombospondin-mimetic peptide, ABT-898, suppresses angiogenesis and promotes follicular atresia in pre- and early-antral follicles in vivo.

20883985

Ib??ez L

2011

Early metformin therapy to delay menarche and augment height in girls with precocious pubarche.

20883990

Celik O

2011

An appraisal of serum preptin levels in PCOS.

20886012

Bordini B

2010

LH Dynamics in Overweight Girls with Premature Adrenarche and Slowly Progressive Sexual Precocity.

20888116

Caglar GS

2011

The association of urinary albumin excretion and metabolic complications in polycystic ovary syndrome.

20889251

Olszanecka-Glinianowicz M

2011

Serum adiponectin and resistin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.

20923278

Torvinen A

2011

Metabolic and reproductive characteristics of first-degree relatives of women with self-reported oligo-amenorrhoea and hirsutism.

20925278

Vrb?kov? J

2010

[The prevalence of metabolic syndrome in women with polycystic ovary syndrome].

20925997

Cheng J

2010

Clinical outcomes of ovulation induction with metformin, clomiphene citrate and human menopausal gonadotrophin in polycystic ovary syndrome.

20926464

Honour JW

2010

Spironolactone interference in the immunoassay of androstenedione.

20926533

Vanky E

2010

Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study.

20926534

Hutchison SK

2011

Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome.

20926690

Velazquez MA

2011

Increased apoptosis in bovine blastocysts exposed to high levels of IGF1 is not associated with downregulation of the IGF1 receptor.

20927764

Tieu J

2010

Oral anti-diabetic agents for women with pre-existing diabetes mellitus/impaired glucose tolerance or previous gestational diabetes mellitus.

20929122

Zhang XJ

2010

[Prelimary exploration on Chinese medicine syndrome type distribution in patients with polycystic ovary syndrome].

20931804

de la Fuente-Valero J

2010

[Sonographic ovarian vascularization and volume in women with polycystic ovary syndrome treated with clomiphene citrate and metformin].

20939675

Abu Hashim H

2010

N-acetyl cysteine plus clomiphene citrate versus metformin and clomiphene citrate in treatment of clomiphene-resistant polycystic ovary syndrome: a randomized controlled trial.

20939704

Bremer AA

2010

Polycystic ovary syndrome in the pediatric population.

20940139

Kristensen SL

2010

A very large proportion of young Danish women have polycystic ovaries: is a revision of the Rotterdam criteria needed?

20940513

Arabzadeh S

2010

Comparing serum basal and follicular fluid levels of anti-M?llerian hormone as a predictor of in vitro fertilization outcomes in patients with and without polycystic ovary syndrome.

20940680

Brewer M

2010

A review of polycystic ovarian syndrome in adolescents.

20942923

Falbo A

2010

Changes in androgens and insulin sensitivity indexes throughout pregnancy in women with polycystic ovary syndrome (PCOS): relationships with adverse outcomes.

20943105

Aziz N

2010

Laparoscopic evaluation of female factors in infertility.

20943333

Lambrinoudaki I

2011

Cardiovascular risk in postmenopausal women with the polycystic ovary syndrome.

20943702

Veltman-Verhulst SM

2010

Sex hormone-binding globulin concentrations before conception as a predictor for gestational diabetes in women with polycystic ovary syndrome.

20943753

Jedel E

2011

Impact of electro-acupuncture and physical exercise on hyperandrogenism and oligo/amenorrhea in women with polycystic ovary syndrome: a randomized controlled trial.

20944055

Downs JS

2010

Implications of type 2 diabetes on adolescent reproductive health risk: an expert model.

20949356

Zangeneh FZ

2011

The effect of cold stress on polycystic ovary syndrome in rat: before and during modeling.

20953904

Fearnley EJ

2010

Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case-control study.

20956435

Pasquali R

2011

Heterogeneity in the responsiveness to long-term lifestyle intervention and predictability in obese women with polycystic ovary syndrome.

20959387

Li C

2011

Association of rs10830963 and rs10830962 SNPs in the melatonin receptor (MTNR1B) gene among Han Chinese women with polycystic ovary syndrome.

20959718

Rizzo M

2011

Assessing cardiovascular risk in Mediterranean women with polycystic ovary syndrome.

20960113

Karadeniz M

2010

Methylenetetrahydrofolate reductase C677T gene polymorphism in Turkish patients with polycystic ovary syndrome.

20960794

Ashida K

2010

[DHEA, DHEA-S].

20960818

Minami S

2010

[Inhibin.activin].

20960819

So A

2010

[Antim?llerian hormone (AMH)].

20961180

Mojiminiyi OA

2010

Variations in alanine aminotransferase levels within the normal range predict metabolic and androgenic phenotypes in women of reproductive age.

20961922

Sloboda DM

2011

Reproduction in females: the role of the early life environment.

20963558

Mu Y

2010

Interleukin 1 beta (IL-1?) promoter C [-511] T polymorphism but not C [+3953] T polymorphism is associated with polycystic ovary syndrome.

20963561

Macut D

2010

Age, body mass index, and serum level of DHEA-S can predict glucocorticoid receptor function in women with polycystic ovary syndrome.

20964873

Yang Y

2010

Association of polymorphisms of interleukin-18 gene promoter region with polycystic ovary syndrome in chinese population.

20965306

Rassi A

2010

Prevalence of psychiatric disorders in patients with polycystic ovary syndrome.

20965504

Akg?l S

2011

CYP1A1 polymorphism in adolescents with polycystic ovary syndrome.

20970114

Decoudier B

2010

Isolated FSH deficiency revealing a granulosa cell tumor.

20974360

Griffin Y

2010

Radiology of benign disorders of menstruation.

20974419

Graves BW

2010

The obesity epidemic: scope of the problem and management strategies.

20974706

Pepene CE

2011

Circulating osteoprotegerin and soluble receptor activator of nuclear factor ?B ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction.

20975725

Reilly JJ

2011

Long-term impact of overweight and obesity in childhood and adolescence on morbidity and premature mortality in adulthood: systematic review.

20979887

Zhao Y

2010

[Clinical features, reproductive endocrine and metabolic abnormalities of adolescent girls with polycystic ovary syndrome].

20979996

Azziz R

2011

Polycystic ovary syndrome: an ancient disorder?

20980429

Wang ET

2011

Menstrual irregularity and cardiovascular mortality.